(Q44932436)

English

Effect of recombinant factor VIIa variant (NN1731) on platelet function, clot structure and force onset time in whole blood from healthy volunteers and haemophilia patients

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

7 December 2017

Effect of recombinant factor VIIa variant (NN1731) on platelet function, clot structure and force onset time in whole blood from healthy volunteers and haemophilia patients (English)

1 reference

Europe PubMed Central

PubMed publication ID

7 December 2017

0 references

1 reference

based on heuristic

inferred from title

author name string

Brophy DF

1

1 reference

Europe PubMed Central

PubMed publication ID

7 December 2017

Martin EJ

2

1 reference

Europe PubMed Central

PubMed publication ID

7 December 2017

Nolte ME

3

1 reference

Europe PubMed Central

PubMed publication ID

7 December 2017

Kuhn JG

4

1 reference

Europe PubMed Central

PubMed publication ID

7 December 2017

Carr ME Jr

5

1 reference

Europe PubMed Central

PubMed publication ID

7 December 2017

publication date

1 September 2007

1 reference

Europe PubMed Central

PubMed publication ID

7 December 2017

1 reference

Europe PubMed Central

PubMed publication ID

7 December 2017

13

1 reference

Europe PubMed Central

PubMed publication ID

7 December 2017

5

1 reference

Europe PubMed Central

PubMed publication ID

7 December 2017

533-541

1 reference

Europe PubMed Central

PubMed publication ID

7 December 2017

Why do inhibitors develop? Principles of and factors influencing the risk for inhibitor development in haemophilia

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2007.01524.X

21 January 2018

The epidemiology of inhibitors in haemophilia A: a systematic review

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2007.01524.X

21 January 2018

Recombinant factor VIIa (Eptacog Alfa): a review of its use in congenital or acquired haemophilia and other congenital bleeding disorders

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2007.01524.X

21 January 2018

Mechanism of action, development and clinical experience of recombinant FVIIa

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2007.01524.X

21 January 2018

Mechanism of factor VIIa-dependent coagulation in hemophilia blood

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2007.01524.X

21 January 2018

Platelet activity of high-dose factor VIIa is independent of tissue factor

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2007.01524.X

21 January 2018

Haemophilias A and B.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2007.01524.X

21 January 2018

Unresponsiveness to factor VIII inhibitor bypassing agents during haemostatic treatment for life-threatening massive bleeding in a patient with haemophilia A and a high responding inhibitor

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2007.01524.X

21 January 2018

Augmented intrinsic activity of Factor VIIa by replacement of residues 305, 314, 337 and 374: evidence of two unique mutational mechanisms of activity enhancement

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2007.01524.X

21 January 2018

Variants of recombinant factor VIIa with increased intrinsic activity.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2007.01524.X

21 January 2018

Rational design of coagulation factor VIIa variants with substantially increased intrinsic activity.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2007.01524.X

21 January 2018

A variant of recombinant factor VIIa with enhanced procoagulant and antifibrinolytic activities in an in vitro model of hemophilia

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2007.01524.X

21 January 2018

Factor VIIa analogue (V158D/E296V/M298Q-FVIIa) normalises clot formation in whole blood from patients with severe haemophilia A.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2007.01524.X

21 January 2018

Improved hemostasis with superactive analogs of factor VIIa in a mouse model of hemophilia A.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2007.01524.X

21 January 2018

Onset of force development as a marker of thrombin generation in whole blood: the thrombin generation time (TGT).

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2007.01524.X

21 January 2018

Development of platelet contractile force as a research and clinical measure of platelet function

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2007.01524.X

21 January 2018

Activity and regulation of factor VIIa analogs with increased potency at the endothelial cell surface

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2007.01524.X

21 January 2018

Identifiers

10.1111/J.1365-2516.2007.01524.X

1 reference

Europe PubMed Central

PubMed publication ID

7 December 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

7 December 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q44932436&oldid=2057995042"